David Haigh

Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription

Matthew P. Coghlan, Ainsley A. Culbert, Darren A.E. Cross et al. · Chemistry & Biology · 2000 · 888 citations · Full text

Biochemistry, Natural Sciences, Glycobiology +7

[[.omega.-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents

Barrie C. C. Cantello, Michael A. Cawthorne, Graham P. Cottam et al. · Journal of Medicinal Chemistry · 1994 · 263 citations

Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma.

Paul Young, Derek R. Buckle, Barrie C. C. Cantello et al. · PubMed · 1998 · 230 citations

Insulin Sensitizer Rosiglitazone, Lipid Peroxidation, Human Adipocytes +16

Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population.

H. J. Bodansky, Anthony Staines, C. R. Stephenson et al. · BMJ · 1992 · 201 citations · Full text

3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3)

David G. Smith, Marianne Buffet, Ashley Fenwick et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 160 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +9